Christine Basmadjian

771 total citations
11 papers, 588 citations indexed

About

Christine Basmadjian is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Christine Basmadjian has authored 11 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Pharmacology. Recurrent topics in Christine Basmadjian's work include Catalytic Alkyne Reactions (2 papers), Synthetic Organic Chemistry Methods (2 papers) and Phytochemical compounds biological activities (2 papers). Christine Basmadjian is often cited by papers focused on Catalytic Alkyne Reactions (2 papers), Synthetic Organic Chemistry Methods (2 papers) and Phytochemical compounds biological activities (2 papers). Christine Basmadjian collaborates with scholars based in France, United States and Netherlands. Christine Basmadjian's co-authors include Laurent Désaubry, Frédéric Thuaud, Nigel Ribeiro, Qian Zhao, Stéphan Vagner, Lise Boussemart, Alexander M.M. Eggermont, Sandrine Agoussi, Oskar Hemmingsson and Caroline Robert and has published in prestigious journals such as Nature, PLoS ONE and Biochemical Journal.

In The Last Decade

Christine Basmadjian

11 papers receiving 580 citations

Peers

Christine Basmadjian
Ragu Kanagasabai United States
Anton Cheltsov United States
Clara Lemos Netherlands
Kay Padget United Kingdom
Ragu Kanagasabai United States
Christine Basmadjian
Citations per year, relative to Christine Basmadjian Christine Basmadjian (= 1×) peers Ragu Kanagasabai

Countries citing papers authored by Christine Basmadjian

Since Specialization
Citations

This map shows the geographic impact of Christine Basmadjian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Basmadjian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Basmadjian more than expected).

Fields of papers citing papers by Christine Basmadjian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Basmadjian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Basmadjian. The network helps show where Christine Basmadjian may publish in the future.

Co-authorship network of co-authors of Christine Basmadjian

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Basmadjian. A scholar is included among the top collaborators of Christine Basmadjian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Basmadjian. Christine Basmadjian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Byrne, Matthew J., Christine Basmadjian, Corine Mas-Droux, et al.. (2020). Nek7 conformational flexibility and inhibitor binding probed through protein engineering of the R-spine. Biochemical Journal. 477(8). 1525–1539. 12 indexed citations
2.
Basmadjian, Christine, et al.. (2015). Novel carbocationic rearrangements of 1-styrylpropargyl alcohols. Beilstein Journal of Organic Chemistry. 11. 1017–1022. 1 indexed citations
3.
Qureshi, Rehana, Adeline Gasser, Christine Basmadjian, et al.. (2015). FL3, a Synthetic Flavagline and Ligand of Prohibitins, Protects Cardiomyocytes via STAT3 from Doxorubicin Toxicity. PLoS ONE. 10(11). e0141826–e0141826. 31 indexed citations
4.
Blanchard, Maxime G., Jeroen H. F. de Baaij, Sjoerd Verkaart, et al.. (2015). Flavaglines Stimulate Transient Receptor Potential Melastatin Type 6 (TRPM6) Channel Activity. PLoS ONE. 10(3). e0119028–e0119028. 11 indexed citations
5.
Han, Jie, Qian Zhao, Christine Basmadjian, Laurent Désaubry, & Arianne L. Theiss. (2015). Flavaglines Ameliorate Experimental Colitis and Protect Against Intestinal Epithelial Cell Apoptosis and Mitochondrial Dysfunction. Inflammatory Bowel Diseases. 22(1). 55–67. 24 indexed citations
6.
Wintachai, Phitchayapak, Frédéric Thuaud, Christine Basmadjian, et al.. (2015). Assessment of flavaglines as potential chikungunya virus entry inhibitors. Microbiology and Immunology. 59(3). 129–141. 52 indexed citations
7.
Boussemart, Lise, Hélène Malka-Mahieu, Isabelle Girault, et al.. (2014). eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies. Nature. 513(7516). 105–109. 261 indexed citations
8.
Basmadjian, Christine, Qian Zhao, Embarek Bentouhami, et al.. (2014). Cancer wars: natural products strike back. Frontiers in Chemistry. 2. 20–20. 96 indexed citations
9.
Basmadjian, Christine, Qian Zhao, & Laurent Désaubry. (2014). Exploratory studies toward a synthesis of flavaglines. A novel access to a highly substituted cyclopentenone intermediate. Tetrahedron Letters. 56(5). 727–730. 9 indexed citations
10.
Basmadjian, Christine, Frédéric Thuaud, Nigel Ribeiro, & Laurent Désaubry. (2013). Flavaglines: Potent Anticancer Drugs that Target Prohibitins and the Helicase eIF4A. Future Medicinal Chemistry. 5(18). 2185–2197. 60 indexed citations
11.
Schrader, Thomas O., Benjamin Johnson, Tawfik Gharbaoui, et al.. (2012). Complementary Asymmetric Routes to (R)-2-(7-Hydroxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetate. Organic Letters. 14(24). 6306–6309. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026